Active	Status	Sponsor type	Region	Phase	Filter
11 Active 11 Inactive 22 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Mraovic, Boris
NCT05887375: Sugammadex Vs Neostigmine/glycopyrrolate on Urinary Retention After Spine Surgery	Enrolling by invitation	4	118	US	Sugammadex, Bridion, MK-8616, Neostigmine, Bloxiverz, Glycopyrrolate, Glycopyrrolate injection, USP, Rocuronium, Rocuronium Bromide	University of Missouri-Columbia, Merck Sharp & Dohme LLC	Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative	07/25	09/25
Murray, Katie
TURBT, NCT06111235: A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following	Recruiting	3	364	Canada, US	Cretostimogene Grenadenorepvec, CG0070, n-dodecyl-B-D-maltoside, DDM	CG Oncology, Inc.	Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer, Urothelial Carcinoma	01/28	01/30